Giammanco, Antonina
Spina, Rossella
Cefalù, Angelo B.
Averna, Maurizio http://orcid.org/0000-0003-3558-9209
Funding for this research was provided by:
Università degli Studi di Palermo
Article History
Accepted: 8 December 2022
First Online: 23 January 2023
Declarations
:
: Antonina Giammanco declares no competing interests. Rossella Spina declares no competing interests. Angelo Baldassare Cefalù has received personal fees for consultancy or grant support from Amryt, Sanofi, and Sobi. Maurizio Averna has received research grant support from Sanofi and Amryt and has served as consultant for Sanofi, Amgen, Amryt, Akcea, Ionis, Alfasigma, and Pfizer.
: This article does not contain any studies with human or animal subjects performed by any of the authors.